{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:41:12Z","timestamp":1787100072532,"version":"build-2736575974"},"reference-count":36,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":330,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/all.12518","type":"journal-article","created":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T00:58:56Z","timestamp":1408928336000},"page":"1689-1695","source":"Crossref","is-referenced-by-count":45,"title":["The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis"],"prefix":"10.1111","volume":"69","author":[{"given":"P.","family":"Devillier","sequence":"first","affiliation":[{"name":"UPRES EA 220; H\u00f4pital Foch; Universit\u00e9 Versailles Saint-Quentin; Suresnes France"},{"name":"D\u00e9l\u00e9gation \u00e0 la Recherche Clinique et \u00e0 l'Innovation; Unit\u00e9 de M\u00e9thodologie; H\u00f4pital Foch; Suresnes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Chassany","sequence":"additional","affiliation":[{"name":"Patient-Reported Outcomes Unit; EA REMES; Universit\u00e9 Paris-Diderot; Sorbonne Paris Cit\u00e9; Paris France"},{"name":"AP-HP; D\u00e9partement de la Recherche Clinique et du D\u00e9veloppement; H\u00f4pital Saint-Louis; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Vicaut","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Recherche Clinique; H\u00f4pital Fernand Vidal; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"de Beaumont","sequence":"additional","affiliation":[{"name":"Stallergenes SA; Antony France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Robin","sequence":"additional","affiliation":[{"name":"Stallergenes SA; Antony France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. F.","family":"Dreyfus","sequence":"additional","affiliation":[{"name":"D\u00e9l\u00e9gation \u00e0 la Recherche Clinique et \u00e0 l'Innovation; Unit\u00e9 de M\u00e9thodologie; H\u00f4pital Foch; Suresnes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Bousquet","sequence":"additional","affiliation":[{"name":"Centre Hospitalier R\u00e9gional Universitaire de Montpellier; Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,10,6]]},"reference":[{"key":"10.1111\/all.12518-BIB0001|all12518-cit-0001","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1164\/ajrccm.162.4.9912033","article-title":"Quality of life in allergic rhinitis and asthma. A population-based study of young adults","volume":"162","author":"Leynaert","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/all.12518-BIB0002|all12518-cit-0002","doi-asserted-by":"crossref","first-page":"S742","DOI":"10.1016\/S0091-6749(97)90000-2","article-title":"Measuring health-related quality of life in rhinitis","volume":"9","author":"Juniper","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12518-BIB0003|all12518-cit-0003","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma","volume":"108","author":"Bousquet","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12518-BIB0004|all12518-cit-0004","unstructured":"EMA European Medicines Agency. Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases 2008"},{"key":"10.1111\/all.12518-BIB0005|all12518-cit-0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1586\/erp.11.12","article-title":"Interpreting patient-reported outcome results: US FDA guidance and emerging methods","volume":"11","author":"McLeod","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1111\/all.12518-BIB0006|all12518-cit-0006","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1398-9995.2006.01276.x","article-title":"Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines","volume":"62","author":"Bousquet","year":"2007","journal-title":"Allergy"},{"key":"10.1111\/all.12518-BIB0007|all12518-cit-0007","first-page":"65","article-title":"Comparison of rhinometric measurements methods in intranasal pathology","volume":"41","author":"Numminen","year":"2003","journal-title":"Rhinology"},{"key":"10.1111\/all.12518-BIB0008|all12518-cit-0008","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1081-1206(10)62160-6","article-title":"Symptom severity assessment of allergic rhinitis: part 1","volume":"91","author":"Spector","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1111\/all.12518-BIB0009|all12518-cit-0009","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0091-6749(98)70380-X","article-title":"Measuring quality of life in children with rhinoconjunctivitis","volume":"101","author":"Juniper","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12518-BIB0010|all12518-cit-0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0091-6749(94)90349-2","article-title":"Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials","volume":"93","author":"Juniper","year":"1994","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12518-BIB0011|all12518-cit-0011","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0091-6749(99)70380-5","article-title":"Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire","volume":"104","author":"Juniper","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12518-BIB0012|all12518-cit-0012","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jclinepi.2007.03.012","article-title":"Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes","volume":"61","author":"Revicki","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/all.12518-BIB0013|all12518-cit-0013","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jaci.2009.02.033","article-title":"Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis","volume":"123","author":"Bousquet","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12518-BIB0014|all12518-cit-0014","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/cea.12121","article-title":"Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis","volume":"43","author":"Demoly","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.12518-BIB0015|all12518-cit-0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0091-6749(96)70135-5","article-title":"Interpretation of rhinoconjunctivitis quality of life questionnaire data","volume":"98","author":"Juniper","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12518-BIB0016|all12518-cit-0016","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaci.2012.10.022","article-title":"Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis","volume":"131","author":"Meltzer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12518-BIB0017|all12518-cit-0017","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2006.01312.x","article-title":"Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce","volume":"62","author":"Canonica","year":"2007","journal-title":"Allergy"},{"issue":"Suppl 91","key":"10.1111\/all.12518-BIB0018|all12518-cit-0018","first-page":"1","article-title":"Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009","volume":"64","author":"Canonica","year":"2009","journal-title":"Allergy"},{"key":"10.1111\/all.12518-BIB0019|all12518-cit-0019","unstructured":"FDA Guidance for industry. Allergic rhinitis: clinical development programs for drug products 2000 2718"},{"key":"10.1111\/all.12518-BIB0020|all12518-cit-0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1365-2222.2009.03381.x","article-title":"The minimal clinically important difference in allergic rhinitis","volume":"40","author":"Barnes","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1111\/all.12518-BIB0021|all12518-cit-0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","article-title":"Determining a minimal important change in a disease-specific Quality of Life Questionnaire","volume":"47","author":"Juniper","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/all.12518-BIB0022|all12518-cit-0022","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"key":"10.1111\/all.12518-BIB0023|all12518-cit-0023","first-page":"41","article-title":"Detecting worms, ducks, and elephants: a simple approach for defining clinically relevant effects in quality-of-life measures","volume":"1","author":"Sloan","year":"2003","journal-title":"J Cancer Integr Med"},{"key":"10.1111\/all.12518-BIB0024|all12518-cit-0024","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1179\/2042618612Y.0000000001","article-title":"Clinimetrics corner: a closer look at the minimal clinically important difference (MCID)","volume":"20","author":"Wright","year":"2012","journal-title":"J Man Manip Ther"},{"key":"10.1111\/all.12518-BIB0025|all12518-cit-0025","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jclinepi.2004.01.012","article-title":"A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale","volume":"57","author":"Eton","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1111\/all.12518-BIB0026|all12518-cit-0026","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"key":"10.1111\/all.12518-BIB0027|all12518-cit-0027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jclinepi.2009.01.024","article-title":"The minimal detectable change cannot reliably replace the minimal important difference","volume":"63","author":"Turner","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"Suppl 2","key":"10.1111\/all.12518-BIB0028|all12518-cit-0028","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1111\/j.1524-4733.2007.00274.x","article-title":"Interpreting and reporting results based on patient-reported outcomes","volume":"10","author":"Revicki","year":"2007","journal-title":"Value Health"},{"key":"10.1111\/all.12518-BIB0029|all12518-cit-0029","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0885-3924(02)00529-8","article-title":"Combining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales","volume":"24","author":"Cella","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/all.12518-BIB0030|all12518-cit-0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.spinee.2007.01.008","article-title":"Understanding the minimum clinically important difference: a review of concepts and methods","volume":"7","author":"Copay","year":"2007","journal-title":"Spine J"},{"key":"10.1111\/all.12518-BIB0031|all12518-cit-0031","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaci.2009.06.053","article-title":"The minimally important difference of the Asthma Control Test","volume":"124","author":"Schatz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/all.12518-BIB0032|all12518-cit-0032","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4065\/77.4.371","article-title":"Clinical Significance Consensus Meeting G. Methods to explain the clinical significance of health status measures","volume":"77","author":"Guyatt","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/all.12518-BIB0033|all12518-cit-0033","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1183\/09031936.00117509","article-title":"Asthma Control Questionnaire in children: validation, measurement properties, interpretation","volume":"36","author":"Juniper","year":"2010","journal-title":"Eur Resp J"},{"key":"10.1111\/all.12518-BIB0034|all12518-cit-0034","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1477-7525-11-59","article-title":"Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT)","volume":"11","author":"Le","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"10.1111\/all.12518-BIB0035|all12518-cit-0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.02.00063702","article-title":"Interpreting thresholds for a clinically significant change in health status in asthma and COPD","volume":"19","author":"Jones","year":"2002","journal-title":"Eur Resp J"},{"key":"10.1111\/all.12518-BIB0036|all12518-cit-0036","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2222.2000.00668.x","article-title":"Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire","volume":"30","author":"Juniper","year":"2000","journal-title":"Clin Exp Allergy"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fall.12518","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T22:04:48Z","timestamp":1625436288000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/all.12518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,6]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1111\/all.12518","relation":{},"ISSN":["0105-4538"],"issn-type":[{"value":"0105-4538","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10,6]]}}}